Children with Unilateral Cerebral Palsy (UCP) often experience reduced spontaneous use of the non-dominant upper limb in daily life. Traditional clinical assessments, such as the Assisting Hand Assessment (AHA), provide valuable but clinical-environment-related and thus episodic measures of functional performance in structured settings. There remains a critical need for tools that enable continuous, ecologically valid, and objective monitoring of upper limb activity in real-world environments. In this study, we introduce the Daily AHA Biomarker (DAB), a novel digital biomarker derived from wearable sensor data, designed to estimate AHA scores based on spontaneous motor behavior. The DAB is intended to be used in clinical practice to monitor the movement of the upper extremities of subjects with UCP in their naturalistic environments. Using bilateral wrist-worn accelerometers, we collected multiday time-series data from 80 children (54 with UCP and 26 with Typical Development). Our Machine Learning pipeline combines time-series classification and regression to predict AHA scores from unstructured, daily living-recorded data. The final DAB indicator showed high predictive accuracy () and a strong correlation with the clinical AHA score and the Manual Ability Classification System (MACS) level.

Machine Learning to Identify a New Digital Biomarker to Monitor Everyday Upper Limb Use in Children with Unilateral Cerebral Palsy

Filogna S.;Prencipe G.
;
Sirbu A.;Beani E.;Sgandurra G.
Ultimo
2026-01-01

Abstract

Children with Unilateral Cerebral Palsy (UCP) often experience reduced spontaneous use of the non-dominant upper limb in daily life. Traditional clinical assessments, such as the Assisting Hand Assessment (AHA), provide valuable but clinical-environment-related and thus episodic measures of functional performance in structured settings. There remains a critical need for tools that enable continuous, ecologically valid, and objective monitoring of upper limb activity in real-world environments. In this study, we introduce the Daily AHA Biomarker (DAB), a novel digital biomarker derived from wearable sensor data, designed to estimate AHA scores based on spontaneous motor behavior. The DAB is intended to be used in clinical practice to monitor the movement of the upper extremities of subjects with UCP in their naturalistic environments. Using bilateral wrist-worn accelerometers, we collected multiday time-series data from 80 children (54 with UCP and 26 with Typical Development). Our Machine Learning pipeline combines time-series classification and regression to predict AHA scores from unstructured, daily living-recorded data. The final DAB indicator showed high predictive accuracy () and a strong correlation with the clinical AHA score and the Manual Ability Classification System (MACS) level.
2026
Filogna, S.; Prencipe, G.; Sirbu, A.; Beani, E.; Marchi, D.; Scerra, G.; Sgandurra, G.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11568/1360867
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
social impact